PPARG and inflammatory bowel disease: Second, we confirmed that the activation of PPARγ could inhibit the repolarization of macrophages from the M2 phenotype to the M1 phenotype and maintain the M2 phenotype in RAW264.7 cells and colon tissues to attenuate IBD.